20/20 BioLabs develops and commercializes cutting-edge, AI-powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases.
The company's advanced diagnostics leverage machine learning algorithms built on extensive real-world data, offering exceptional accuracy and convenience for individuals and providers.
